Gypenoside LXXV
Modify Date: 2024-01-10 18:36:23
Gypenoside LXXV structure
|
Common Name | Gypenoside LXXV | ||
|---|---|---|---|---|
| CAS Number | 110261-98-8 | Molecular Weight | 785.01 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C42H72O13 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Gypenoside LXXVGypenoside LXXV, isolated from Gynostemma pentaphyllum, is one of the deglycosylated shapes of ginsenoside Rb1. Gypenoside LXXV significantly reduces cancer cell viability and displays an anti-cancer effect[1]. |
| Name | Gypenoside LXXV |
|---|
| Description | Gypenoside LXXV, isolated from Gynostemma pentaphyllum, is one of the deglycosylated shapes of ginsenoside Rb1. Gypenoside LXXV significantly reduces cancer cell viability and displays an anti-cancer effect[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Gypenoside LXXV (1.0-100 μM; for 48 hours) reduces proliferation in a dose-dependent manner[1]. Cell Viability Assay[1] Cell Line: Three cancer cell lines (HeLa (cervical cancer cell line), B16 (melanoma cell line), and MDA-MB231 (human breast cancer cell line) Concentration: 1.0-100 μM Incubation Time: For 48 hours Result: Reduced proliferation in a dose-dependent manner and inhibited almost all cancer cells at 50 μM. |
| References |
| Molecular Formula | C42H72O13 |
|---|---|
| Molecular Weight | 785.01 |
| Storage condition | 2-8℃ |